The Snowdome Foundation is proud to be partnering with the Leukemia & Lymphoma Society (LLS) to fund two US$600,000 translational research grants. Snowdome’s mission is to accelerate next-generation treatments for Australian blood cancer patients to help them live longer, better lives.
To help us achieve our mission, we are co-funding two translational research project applications focused on blood cancer, especially work focused on multiple myeloma. To be eligible, applicants must be working in Australia, Australian investigators working in other countries, or Australian and non-Australian researchers jointly applying as co-PIs. Applications must be submitted to the LLS Translational Research Program (TRP) and will be evaluated within the general pool of TRP applications. In addition, applications will be jointly reviewed by both foundations to ensure they meet the funding objectives of both organisations, and scientific progress. LLS will administer the grant program.
Each Applicant must submit the LOI by August 31, 2018 at 3:00 pm US Eastern Daylight Time via the LLS Research Portal (https://lls.fluxx.io).
For more information visit http://www.lls.org/research/translational-research-program.